GMS | 22nd Annual Meeting of the German Retina Society

Tatar O, Shinoda K, Kaiserling E, Kirchhof B, Scharioth G, Eckardt C, Eckert T, Lucke K, Bopp S, Pertile G, Yoeruek E, Grisanti S, Bartz-Schmidt KU
[Full Text]

Meeting Abstract (RG2009-23)

PEDF-based, non-viral gene therapy for retinal degeneration

Johnen S, Maltusch C, Thumann G
[Full Text]

Meeting Abstract (RG2009-24)

Nanofibrillar Vs. Smooth: Influence Of Surface Characteristics On Cultured Human RPE Behavior

Stanzel BV, Thieltges F, Englander M, Strick DJ, Binder S, Holz FG, Marmor MF
[Full Text]

Meeting Abstract (RG2009-25)

Tissue-engineered biodegradable membranes for subretinal transplantation

Salz AK, Thumann G
[Full Text]

Meeting Abstract (RG2009-26)

Flat mounted internal limiting membrane preparation

Schumann RG, Scheler R, Schaumberger MM, Haritoglou C, Kampik A, Gandorfer A
[Full Text]

Meeting Abstract (RG2009-27)

Development of the visual acuity after ILM-peeling for epiretinal gliosis with and without staining with indocyanine green

Schüler A, Bopp S, Lucke K
[Full Text]

Meeting Abstract (RG2009-28)

Retrospective evaluation of transconjunctival 23g vitrectomy in retinal detachment

Kieselbach G, Strasser M, Kremser B, Schmid E, Kralinger M
[Full Text]

Meeting Abstract (RG2009-29)

Visual acuity and subfoveal fluid after successful detachment surgery: Scleral buckling vs. Vitrectomy

Kaymak H, Schmitt R, Mester U
[Full Text]

Meeting Abstract (RG2009-30)

Comparison of silicone oil flow rates depending on the cannula type and pressure applied: Focus on Siluron 2000

Kaymak H, Hagedorn N, Lingenfelder C, Mester U
[Full Text]

Meeting Abstract (RG2009-31)

Heavy silicone oil tamponade in patients with persistent macular holes or recurrent epiretinal membrane formation

Hattenbach L, Höhn F, Shishkova G, Mirshahi A
[Full Text]

Meeting Abstract (RG2009-32)

Giant retinal tear management with silicone oil tamponade: incidence of unexplained visual loss

Bopp S, Schüler A, Lucke K
[Full Text]

Meeting Abstract (RG2009-33)

Endophthalmitis after Cataract surgery: vitrectomy without systemic antibiotics?

Margolina E, Hoerauf H, Müller M
[Full Text]

Meeting Abstract (RG2009-34)

ROP-Screening Results Cologne 2001–2008

Muether PS, Schumacher J, Kirchhof B, Fauser S
[Full Text]

Meeting Abstract (RG2009-35)

Incontinentia pigmenti: 11 patients with ocular involvement

Doblhofer M, Willerding G, Ottenberg D, Bechrakis NE, Jandeck C, Foerster M
[Full Text]

Meeting Abstract (RG2009-36)

PuriProtect^® – a new neuroprotective irrigation solution for vitrectomy?

Schultheiss M, Ruschenburg H, Spitzer MS, Januschowski K, Warga M, Bartz-Schmidt KU, Szurman P
[Full Text]

gms | German Medical Science

22nd Annual Meeting of the German Retina Society

IV. Free papers I

Ranibizumab – transferable from multicenter study to clinical practice?

Effects of Ranibizumab in patients with subfoveal choroidal neovascularization attributable to age-related macular degeneration

Intravitreal anti-VEGF-therapy in myopic CNV – Overview of literature and own experiences

Intravitreal Ranibizumab (Lucentis^®) is more effective than intravitreal Pegaptanib (Macugen^®) in treating exsudative age-related macular degeneration for patients with history of cardiovascular accidents

Effect of intravitreal bevacizumab on retinal pigment epithelium detachment due to occult choroidal neovascularisation

VEGF levels in serum and breast milk after repeated intravitreal injection of Bevacizumab and Ranibizumab – a case report

Nanotechnology in the treatment of choroidal neovascularization secondary to AMD: First in vitro results using laser-activated gold-nanoparticles

Early Effects of Triamcinolone Acetonide on Matrix Metalloproteinases and Endostatin in Human Choroidal Neovascularization